ATLANTA, Feb. 11 Sensiotec Inc. announces FDA 510(k) ClassII clearance for the world's first ultra-wideband (UWB) non-contact,continuous monitor for heart and respiration rates, bed occupancy andmovement. Under the brand name Preventa(TM), Sensiotec will market and sellthe medical device in the US and Canada under an exclusive worldwide licensewith its affiliate, Wireless 2000. Wireless 2000 received the sign off fromthe FDA's Division of Cardiovascular Devices.
Preventa(TM) is the first medical device to harness the potential of UWB,an emerging wireless communications standard and former classified militarytechnology, creating a wireless vital signs monitor. In 2002, the FCCauthorized the use of UWB for the development of new imaging systems to "see"inside the human body. Sensiotec CEO Robert Arkin states, "We're excited bythe opportunity with Preventa(TM) to make a difference in people's livesthrough improved disease management while also addressing society's need tohelp contain runaway healthcare costs."
Preventa(TM) monitors heart and respiration rates, bed occupancy andmovement on a continuous, real-time, remote basis, "watching" patients 100% ofthe time from a monitoring station down the hall or even 1,500 miles away.Caregivers gain a disease management tool that can help reduce complicationsassociated with common chronic illnesses (such as heart disease, COPD andsleep apnea), optimize scarce human resources, and reduce hospital admissionsand ER visits. Preventa(TM) also alerts caregivers when a patient requires anassisted relocation to help prevent bed sores. Using additional proprietarycomponents, Preventa(TM) tracks roaming physical assets and protects wanderingat-risk patients (locking exit doors or elevators automatically). SensiotecCTO Efraim Gavrilovich states, "Wireless monitoring has great potential as anearly warning system that helps to identify and manage health crises when theyarise."
Sensiotec Inc. is a development stage company based in Atlanta, Georgia.Sensiotec's value proposition is to commercialize next-generation wirelessmedical monitoring devices that improves healthcare quality and safety, andreduces costs. Sensiotec's strategic intent is to market Preventa(TM) in 2009.Media Contacts: (404) 550-5329 Alison Goldwater, email@example.com Linda Pakula, firstname.lastname@example.org Corporate Contact: Robert Arkin: (404) 452-1891, email@example.com
SOURCE Sensiotec Inc.